Abstract
Introduction

Hepatic veno-occlusive disease (VOD) is a clinical syndrome characterized by jaundice, liver enlargement accompanied by pain and weight gain due to fluid retention. It is one of the lethal complications that may occur following allogeneic hematopoietic stem cell transplantation (HST) because various complications resulting from VOD include multiorgan failure showing thrombocytopenia with refractoriness to transfusions, coagulopathy, pleural effusion, renal failure and respiratory failure. Clinical criteria for diagnosis of VOD following bone marrow transplantation (BMT) have been developed by two independent groups. The criteria proposed by the Seattle group specify the occurrence of two of the following events within 20 days of transplantation:
hyperbilirubinemia (total serum bilirubin >2 mg/dL), hepatomegaly or right upper quadrant pain of liver origin, and sudden weight gain (>2% of baseline body weight) because of fluid accumulation (1) . The other criteria proposed by the Baltimore group specify hyperbilirubinemia peaking at 2 mg/dL or more in conjunction with at least two of three other findings: hepatomegaly, ascites, and 5% or greater weight gain within the first 3 weeks after marrow infusion (2) .
Accurate and early diagnosis of VOD is clinically important because the reported fatality rate is greater than 20% (2) (3) (4) (5) . Jones et There are many reports on the role of ultrasonography in the diagnosis of VOD (7) (8) (9) (10) (11) (12) (13) T a b l e 1 . Ul t r a s o n o g r a p h i c Me a s u r e me n t s a n d L a b o r a t o r 
no change of medication including antimicrobial agents at this time, and the absence of weight gain and fluid retention is usually sufficient to distinguish VOD from other forms of early liver injury with jaundice including regimen-related toxicity and infections (16), we diagnosed this severe hyperbilirubinemia as a case of VOD. Even though the serum bilirubin had not peaked yet, ultrasonography showed diminished ascites and gallbladder wall
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thickening (8.9 g u r e 3 . L o n g i t u d i n a l c o u r s e s o f p o r t a l v e n o u s f l o w, g a l l b l a d d e r wa l l t h i c k e n i n g , s e r u m b i l i r u  b i n a n d b l o o d c o n c e n t r a t i o n o f c y c l o s p o r i n A. promptly with complete response (19) . Twenty-seven months after the transplantation, our patient remains in good condition, showing continuing CR without liver dysfunction.
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Discussion
The patient who is the subject of this report was noninvasively diagnosed as having VOD (8, 10) although they were found to be not necessarily associated with VOD or were nonspecific for its diagnosis in several studies (7, 11, 12) .
In the present patient, the early detection of hepatomegaly, ascites, gallbladder wall thickening and reversed portal venous flow was of diagnostic value. By using ultrasonography, these findings were detected before serum bilirubin had reached 2 mg/dL, as specified in the diagnostic criteria. Bearman reported that hepatomegaly and fluid retention was followed by hyperbilirubinemia in patients with VOD (16 
